Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.

Abstract

Human herpesvirus 6 (HHV-6) is increasingly recognized as a potentially life-threatening pathogen in allogeneic hematopoietic stem cell transplantation (alloSCT). We retrospectively evaluated 54 adult patients who developed positivity to HHV-6 after alloSCT. The median time from alloSCT to HHV-6 reactivation was 34 days. HHV-6 was present in plasma samples… (More)
DOI: 10.1016/j.bbmt.2016.09.018

Topics

  • Presentations referencing similar topics